Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?'

Affiliations

• ¹ Division of Rheumatology, University of Toronto and Toronto Western Hospital, Toronto, Ontario, Canada [email protected].
• ² Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA.
• ³ Rheumatology, University of New Sounth Wales, Sydney, New South Wales, Australia.
• ⁴ Rheumatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
• ⁵ Immunology, Janssen Scientific Affairs LLC, Horsham, Pennsylvania, USA.
• ⁶ Rheumatology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
• ⁷ Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Horsham, PA, USA.
• ⁸ Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Paris, France.
• ⁹ Division of Gastroenterology, Infectious Diseases and Rheumatology, Charité Universitätsmedizin Berlin, Berlin, Germany.
• ¹⁰ Department of Medicine and Therapeutics, Chinese University of Hong Kong, New Territories, Hong Kong.
• ¹¹ Academic Unit of Musculoskeletal Medicine, University of Leeds, School of Medicine, Leeds, UK.
• ¹² Department of Medicine, School of Medicine, University of California at San Diego, La Jolla, California, USA.
• ¹³ Division of Arthritis/Rheumatic Diseases (OPO9), Oregon Health & Science University, Portland, Oregon, USA.
• ¹⁴ Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark.
• ¹⁵ Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany.